Michael Nissen

7PUBLICATIONS
36CO-AUTHORS
Major global burdens of diseasePowder and particle technologyEpidemiological modellingPacific Peoples theory of change models for healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2026
Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries.

|Feb 23, 2026
Replacing ADT With dTpa in Queensland Emergency Departments: Another Opportunity for Pertussis Control?

Michael D Nissen, Faye Jordan, Polash Adhikari

|Nov 10, 2025
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8.

Paul T Scott, Jayani Pathirana, Akira Kato

|Nov 04, 2021
The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region.

Leong Hoe Nam, Cheng-Hsun Chiu, Jung Yeon Heo

|Apr 13, 2021
High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS.

Sarah J Tozer, Helen V Smith, David M Whiley

|Jul 24, 2020
Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis.

Julianne Bayliss, Roshnee Randhawa, Kyu-Bin Oh

Pageof 2

Frequent Collaborators

2 joint publications

Julianne Bayliss

1 joint publications

Sarah J Tozer

1 joint publications

Helen V Smith

1 joint publications

David M Whiley